Hisamitsu Pharmaceutical Completes $428 Million Noven Pharmaceuticals Inc. (NOVN) Purchase
8/28/2009 7:13:21 AM
More...
|
Hisamitsu Pharmaceutical Announces Expiration of Subsequent Offering Period and Completion of Tender Offer for Outstanding Shares of Noven Pharmaceuticals Inc. (NOVN)
8/27/2009 10:14:39 AM
More...
|
Hisamitsu Pharmaceutical Announces Expiration of Initial Tender Offer Period for Outstanding Shares of Noven Pharmaceuticals Inc. (NOVN) and Commencement of Subsequent Offering Period
8/20/2009 8:44:08 AM
More...
|
Hisamitsu Pharmaceutical Announces Expiration of HSR Waiting Period for Its Proposed Acquisition of Noven Pharmaceuticals Inc. (NOVN)
8/13/2009 12:19:27 PM
More...
|
Hisamitsu Pharmaceutical Begins Tender Offer for All Outstanding Shares of Noven Pharmaceuticals Inc. (NOVN)
7/23/2009 9:06:55 AM
More...
|
Noven Pharmaceuticals Inc. (NOVN) Reports Positive Phase 2 Results for Mesafem(TM) Non-Hormonal Therapy for Vasomotor Symptoms
7/14/2009 9:47:30 AM
More...
|
Japan's Hisamitsu Pharmaceutical to Buy Noven Pharmaceuticals Inc. (NOVN) for $430 Million, To Expand U.S. Presence
7/14/2009 7:03:39 AM
More...
|
Noven Pharmaceuticals Inc. (NOVN) Announces Results of 2009 Annual Meeting of Stockholders
5/22/2009 1:12:28 PM
More...
|
Noven Pharmaceuticals Inc. (NOVN) to Webcast 2009 Annual Meeting of Stockholders
5/21/2009 9:32:44 AM
More...
|
Noven Pharmaceuticals Inc. (NOVN) to Present At Deutsche Bank (DB) Health Care Conference
5/15/2009 9:55:28 AM
More...
|
|